miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors

Y Xu, P Chen, X Wang, J Yao, S Zhuang - Neuroscience Letters, 2018 - Elsevier
Abstract MicroRNA (miR)-34a was recently determined to contribute to the pathological
development of Alzheimer's disease (AD). miR-34a deficiency significantly attenuates …

miR-34a knockout attenuates cognitive deficits in APP/PS1 mice through inhibition of the amyloidogenic processing of APP

C Jian, M Lu, Z Zhang, L Liu, X Li, F Huang, N Xu, L Qin… - Life Sciences, 2017 - Elsevier
The noncoding miRNA-34a (miR-34a) is involved in Alzheimer's disease (AD)
pathologenesis and shows potential for application as a biomarker for early diagnosis and …

miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease

T Sun, K Zhao, M Liu, Z Cai, L Zeng, J Zhang… - Pharmacological …, 2022 - Elsevier
Alzheimer's disease (AD) pathogenesis is known to involve a dysregulation of microRNA
expression, and these intricate transcriptional cascades between multiple pathological …

MicroRNA‐128 suppresses tau phosphorylation and reduces amyloid‐beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's …

S Li, CH Poon, Z Zhang, M Yue, R Chen… - CNS Neuroscience …, 2023 - Wiley Online Library
Abstract Introduction and Aims Alzheimer's disease (AD) is characterized by the abnormal
accumulation of hyperphosphorylated tau proteins and amyloid‐beta (Aβ) peptides. Recent …

A novel mechanism of synaptic and cognitive impairments mediated via microRNA-30b in Alzheimer's disease

Y Song, M Hu, J Zhang, Z Teng, C Chen - EBioMedicine, 2019 - thelancet.com
Background It is widely accepted that cognitive and memory deficits in Alzheimer's disease
(AD) primarily result from synaptic failure. However, the mechanisms that underlie synaptic …

MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice

W Liu, C Liu, J Zhu, P Shu, B Yin, Y Gong, B Qiang… - Neurobiology of …, 2012 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder mainly characterized
by amyloid-beta (Aβ) deposition and neurofibrillary tangles (NFTs). The abnormal …

[HTML][HTML] MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice

J Li, D Li, H Zhou, G Wu, Z He, W Liao, Y Li… - Aging (Albany NY …, 2020 - ncbi.nlm.nih.gov
MicroRNAs have become pivotal modulators in the pathogenesis of Alzheimer's disease.
MiR-338-5p is associated with neuronal differentiation and neurogenesis, and expressed …

miR-23b-3p rescues cognition in Alzheimer's disease by reducing tau phosphorylation and apoptosis via GSK-3β signaling pathways

H Jiang, J Liu, S Guo, L Zeng, Z Cai, J Zhang… - … Therapy-Nucleic Acids, 2022 - cell.com
Dysregulated microRNA (miRNA) expression in the brain can contribute to cognitive
dysfunction and aberrant tau hyperphosphorylation in Alzheimer's disease (AD). Several …

MicroRNA-34c downregulation ameliorates amyloid-β-induced synaptic failure and memory deficits by targeting VAMP2

S Hu, H Wang, K Chen, P Cheng, S Gao… - Journal of …, 2015 - content.iospress.com
MicroRNAs (miRNAs) are small (∼ 22-nucleotide [nt]) noncoding RNAs that regulate
biological processes at the post-transcriptional level. Dysregulation of specific miRNAs …

Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease

K Lee, H Kim, K An, OB Kwon, S Park, JH Cha… - Scientific reports, 2016 - nature.com
MicroRNAs have emerged as key factors in development, neurogenesis and synaptic
functions in the central nervous system. In the present study, we investigated a …